| Revenue Growth | PowerTrack software up 18%; Edge hardware down 11%; Managed services up 19%. |
|---|---|
| Mgmt Confidence | Confident in software strategy but evasive on strategic review timelines. |
| Demand Visibility | US solar softness noted; customers delaying construction due to ITC phase-out. |
| Order Book | Contracted backlog $22.3M; CARR $70.5M; Solar AUM reached 40GW. |
| Margin Trends | Record 58% non-GAAP gross margin driven by high-margin software mix. |
| Op. Leverage | Adjusted EBITDA $7.1M more than tripled YoY; cash OpEx down 17%. |
| Vol vs Price | Growth driven by software mix shift rather than hardware volume. |
| Segment Growth | PowerTrack ARR grew 14% YoY to $44.4M; Managed services ARR flat. |
| New Clients | New utility-scale project in Republic of Georgia; partnership with Copec Flux. |
| Capex & Debt | Sold Athena IP for $10M; removed $30M liabilities by exiting SPEs. |
| Regulatory | NYSE market cap non-compliance; 10-Q includes going concern disclosure. |
| Commentary | Trading low-quality hardware revenue for simpler, higher-margin software-centric business model. |
| New Launches | PowerTrack Sage, PowerTrack EMS, and Iona AI services offering launched. |
Growth
PowerTrack software revenue grew 18% YoY; total revenue fell 4% to $36.7 million.
Outlook
Raised FY2026 adjusted EBITDA guidance to $15M-$20M; lowered revenue to $132M-$142M.
Risks
Going concern warning in 10-Q, NYSE non-compliance, and US solar bookings down 6%.
The company's earnings call, NYSE: STEM, and its 8-K filed with the SEC. Summary written with AI assistance from the call.
Earnings call webcast ↗ Watch on YouTube ↗
Stem, Inc.: key numbers
- Share price
- $1.97Close, Nov 16
- Market cap
- $19.1M
- Shares outstanding
- 9.72MLatest SEC cover page
- Sector
- Technology
- Industry
- Services-Computer Integrated Systems DesignSIC 7373
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Stem, Inc.
All →Stem Q3 2026 Results: Net Loss of $14.6M, Loss Narrows
Stem, Inc. reported total revenue of $36.7 million for the third quarter of 2026, a slight decrease from $38.2 million in the prior year period. The company saw a significant reduction in net loss to $14.6 million compared to a $23.8 million loss in Q3 2025, driven by improved gross margins and lower operating expenses.
- Key figure
- Net loss $14.6M
Stem Financial Results
Stem, Inc. reported Q3 2026 financial results, highlighting a shift in strategy to focus on its high-margin PowerTrack software while de-emphasizing Managed Services and battery hardware resale. The company achieved record solar assets under management of 40 GW and reported positive adjusted EBITDA of $7.1 million, though it lowered full-year revenue and ARR guidance due to the strategic pivot.
- Term
- Q3 2026
“Our third quarter shows the operating leverage of a business built around PowerTrack. PowerTrack software revenue grew 18% year-over-year, we achieved a record 40 gigawatts of solar assets under management, and we were selected for the first utility-scale solar project in the Republic of Georgia.”
Arun Narayanan, Chief Executive Officer of Stem
“We delivered another quarter of strong margins and adjusted EBITDA, with non-GAAP gross margin of 58% and adjusted EBITDA of $7.1 million, more than triple the third quarter of 2025.”
Brian Musfeldt, Chief Financial Officer of Stem
Stem Leadership Change
Stem, Inc. announced that Saul Laureles, Chief Legal Officer and Secretary, will leave the company effective November 24, 2026. The Board has appointed Jessica Palomino, the company's current Vice President and Senior Counsel – Operations, to succeed him as Chief Legal Officer and Secretary on the same date. Mr. Laureles will remain as a non-executive advisor through December 13, 2026, to ensure an orderly transition.
Stem Nasdaq/NYSE Compliance Notice
Stem, Inc. received a non-compliance letter from the NYSE because its average global market capitalization and stockholders' equity both fell below the $50 million minimum requirement over a 30 trading-day period. The company intends to submit a business plan within 45 days detailing how it will regain compliance within the 18-month cure period. The company's common stock will continue to trade on the NYSE during this period, subject to the exchange's acceptance of the plan.
- Counterparty
- New York Stock Exchange
- Term
- 18 months